Education
About Us
Working with TipRanks
Follow Us
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -16.16B | $ -8.83M | $ -10.54M | $ -9.13M | $ -6.51M |
| EBITDA | $ -15.59M | $ 429.04K | $ -10.54M | $ -9.13M | $ -6.63M |
| Net Income | $ -15.59B | $ -8.40M | $ -10.52M | $ -9.10M | $ -6.30M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 60.21M | $ 7.27M | $ 13.12M | $ 20.30M | $ 16.74M |
| Total Assets | $ 60.29M | $ 7.35M | $ 13.23M | $ 20.52M | $ 16.87M |
| Total Debt | $ 0.00 | $ 0.00 | $ 8.41K | $ 0.00 | $ 0.00 |
| Net Debt | $ -45.82M | $ -7.27M | $ -8.18M | $ -20.30M | $ -16.74M |
| Total Liabilities | $ 5.25M | $ 1.76M | $ 3.14M | $ 1.58M | $ 1.18M |
| Stockholders' Equity | $ 55.04B | $ 5.59M | $ 10.09M | $ 18.94M | $ 15.69M |
| Cash Flow | |||||
| Free Cash Flow | $ -6.40M | $ -7.86M | $ -7.23M | $ -7.32M | $ -4.66M |
| Operating Cash Flow | $ -6.40M | $ -7.86M | $ -7.23M | $ -7.32M | $ -4.66M |
| Investing Cash Flow | $ -14.34M | $ 4.93M | $ -4.92M | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 59.29M | $ 2.03M | $ 32.87K | $ 10.88M | $ 8.18M |